All documents tagged with this AR226 identifier.
| Title / Summary | Year | AR226 Docket | Hash ID | Pages |
|---|---|---|---|---|
| The document describes an in vitro chromosome aberration study conducted by BioReliance for DuPont, focusing on human peripheral blood lymphocytes, and outlines compliance with various regulatory guidelines while noting exceptions regarding the characterization and stability of test articles. | 1995 | AR226-3181 | EvvQR5EkqqgKvvBK6M7GqXgXj | 40 |